Secretion of extracellular factor(s) induced by X-irradiation activates the HIV type 1 long terminal repeat through its κB motif

AIDS Research and Human Retroviruses

Volumn 14, Issue 4, 1998, Pages 353-365

  Faure, Eric ^a   Rameil, Pascal ^b   Lecine, Patrick ^b   Rey, Françoise ^b   Sire, Josephine ^b   Kahn Perles, Brigitte ^b   Imbert, Jean ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ADENYLATE CYCLASE ACTIVATOR; ANTIOXIDANT; BETA GALACTOSIDASE; CHLORAMPHENICOL ACETYLTRANSFERASE; CIS ACTING ELEMENT; CYCLIC AMP; CYCLOHEXIMIDE; CYTOKINE; FORSKOLIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; X IRRADIATION;

EID: 0032031517     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.353     Document Type: Article

References (62)

1. Pantaleo G and Fauci AS: Tracking HIV during disease progression. Curr Opin Immunol 1994;6:600-604.
2. Staal FJ, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D, Deresinski SC, Ross W, Sussman H, Raju PA, et al.: Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses 1992;8:305-311.
3. Ho WZ and Douglas SD: Glutathione and N-acetylcysteine suppression of HIV replication in human monocytes/macrophages in vitro. AIDS Res Hum Retroviruses 1992;8:1249-1253.
4. Peterlin BM, Luciw PA, Barr PJ, and Walker MD: Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci USA 1986;83: 9734-9738.
5. Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C, and Rosenberg M: Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature (London) 1988; 333:78-81.
6. Rosenberg ZF and Fauci AS: Induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retroviruses 1989;5:1-1.
7. Cavard C, Zider A, Vernet M, Bennoun M, Saragosti S, Grimber G, and Briand P: In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. J Clin Invest 1990;86:1369-1374.
8. Nokta M, Belli J, and Pollard R: X-irradiation enhances in vitro human immunodeficiency virus replication: Correlation with cellular levels of cAMP. Proc Soc Exp Biol Med 1992;200:402-408.
9. Zider A, Mashhour B, Fergelot P, Grimber G, Vernet M, Hazan U, Couton D, Briand P, and Cavard C: Dispensable role of the NF-kappa B sites in the UV-induction of the HIV-1 LTR in transgenic mice. Nucleic Acids Res 1993;21:79-86.
10. Libertin CR, Panozzo J, Groh KR, Chang-Liu CM, Schreck S, and Woloschak GE: Effects of gamma rays, ultraviolet radiation, sunlight, microwaves and electromagnetic fields on gene expression mediated by human immunodeficiency virus promoter. Radiat Res 1994;140:91-96.
11. Vicenzi E and Poli G: Ultraviolet irradiation and cytokines as regulators of HIV latency and expression. Chem Biol Interact 1994;91:101-109.
12. Faure E, Cavard C, Zider A, Guillet JP, Resbeut M, and Champion S: X irradiation-induced transcription from the HIV type 1 long terminal repeat. AIDS Res Hum Retroviruses 1995;11:41-43.
13. Woloschak GE, Chang-Liu CM, Panozzo J, and Libertin CR: Low doses of neutrons induce changes in gene expression. Radiat Res 1994;138:556-559.
14. Faure E, Lecine P, Imbert J, and Champion S: Activation of the HIV type 1 long terminal repeat by X-irradiation involves two main Rel/NF-kappa B DNA-binding complexes. AIDS Res Hum Retroviruses 1996;12:1519-1527.
15. Panozzo J, Akan E, Griffiths D, and Woloschak GE: The effects of 5′-fluorouracil and doxorubicin on expression of human immunodeficiency virus type 1 long terminal repeat. Cancer Lett 1996;105:217-223.
16. Kingsman SM and Kingsman AJ: The regulation of human immunodeficiency virus type-1 gene expression. Eur J Biochem 1996; 240:491-507.
17. Baeuerle PA and Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141-179.
18. Roulston A, Lin R, Beauparlant P, Wainberg MA, and Hiscott J: Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiol Rev 1995;59:481-505.
19. Clouse KA, Powell D, Washington I, Poli G, Strebel K, Farrar W, Bartstad B, Kovacs J, Fauci AS, and Folks TM: Monokine regulation of HIV-1 expression in a chronically-infected human T cell clone. J Immunol 1989;142:431-438.
20. Pomerantz RJ, Trono D, Feinberg MB, and Baltimore D: Cells non-productively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell 1990; 62:1271-1276.
21. Duh EJ, Maury WJ, Folks TM, Fauci AS, and Rabson AB: Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 1989;86:5974-5978.
22. Stein B, Kramer M, Rahmsdorf HJ, Ponta H, and Herrlich P: UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of extracellular factor that induces HIV-1 transcription in nonirradiated cells. J Virol 1989;63:4540-4544.
23. Fantini J, Abadie B, Tirard A, Remy L, Ripert JP, El Battari A, and Marvaldi J: Spontaneous and induced dome formation by two clonal cell population derived from a human adenocarcinoma cell line, HT29. J Cell Sci 1986;83:235-249.
24. Sambrook J, Fritsch EF, and Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989.
25. Leonard J, Parrott C, Buckler-White AJ, Turner W, Ross EK, Martin MA, and Rabson AB: The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol 1989;63:4919-4924.
26. Bachelerie F, Alcami J, Arenzana-Seisdedos F, and Virelizier JL: HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes. Nature (London) 1991;350:709-712.
27. Faure E, Lecine P, Lipcey C, Champion S, and Imbert J: Cell-to-cell contact activates the long terminal repeat of human immunodeficiency virus 1 through its kappaB motif. Eur J Biochem 1997;244:568-574.
28. Pepin N, Roulston A, Lacoste J, Lin RT, and Hiscott J: Subcellular redistribution of HTLV-1 tax protein by NF-kappa-B/Rel transcription factors. Virology 1994;204:706-716.
29. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, and Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59: 284-291.
30. Rey MA, Spire B, Dormont D, Barré-Sinoussi F, Montagnier L, and Chermann JC: Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem Biophys Res Commun 1984;121:126-133.
31. Faure E, Lecine P, Imbert J, and Champion S: Activation of the transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat by autologous and heterologous cell-to-cell contact. Cell Mol Biol 1996;42:811-823.
32. Faure E, Yahi N, Zider A, Cavard C, Champion S, and Fantini J: Physical contact with lymphocytes is required for reactivation of the dormant HIV-1 in colonic epithelial cells: Involvement of the HIV-1 LTR. Virus Res 1994;34:1-13.
33. Sen R and Baltimore D: Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism. Cell 1986;47:921-928.
34. Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Le-Bail O, Urban MB, Kourilsky P, Baeuerle PA, and Israel A: The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell 1990; 62:1007-1018.
35. Tewari M, Dobranski P, Mohn KL, Cressman DE, Hsu J, Bravo R, and Taub R: Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex. Mol Cell Biol 1992;12:2898-2908.
36. Schreck R and Baeuerle PA: Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Methods Enzymol 1994;234:151-163.
37. Baeuerle PA and Baltimore D: NF-kappa B - ten years after. Cell 1996;87:13-20.
38. Maity A, Kao GD, Muschel RJ, and McKenna WG: Potential molecular target for manipulating the radiation response. Int J Radiat Oncol Biol Phys 1997;37:639-653.
39. Nokta MA and Pollard RB: Human immunodeficiency virus replication: Modulation by cellular levels of cAMP. AIDS Res Hum Retroviruses 1992;8:1255-1261.
40. Chowdhury MI, Koyanagi Y, Horiuchi S, Hazeki O, Ui M, Kitano K, Golde DW, Takada K, and Yamamoto N: cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrophage lineage: Synergism with TNF-alpha. Virology 1993;194:345-349.
41. Gridley DS: The role of cytokines in radiation therapy for cancer. Cancer J 1996;9:236-242.
42. Poli G and Fauci AS: The role of cytokines in the pathogenesis of HIV disease. In: Human Cytokines: Their Role in Disease and Therapy (Aggarwal BB and Puri PK, eds.). Blackwell Science, Cambridge, Massachusetts, 1995, pp. 421-429.
43. Schwarz KB: Oxidative stress during viral infection - a review. Free Radic Biol Med 1996;21:641-649.
44. Sen CK and Packer L: Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-720.
45. Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum R, and Kufe D: Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest 1991;88:691-695.
46. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, and Ghosh S: I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 1995:80:573-582.
47. Laurence J, Sikder SK, Jhaveri S, and Salmon JE: Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: Blockade by protein kinase inhibitors and relationship to tat-directed trans-activation. Biochem Biophys Res Commun 1990;166:349-357.
48. Lapointe R, Lemieux R, Olivier M, and Darveau A: Tyrosine kinase and cAMP-dependent protein kinase activities in CD40-activated human B lymphocytes. Eur J Immunol 1996;26:2376-2382.
49. Satriano J and Schlondorff D: Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′,5′-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J Clin Invest 1994;94:1629-1636.
50. Ollivier V, Parry GCN, Cobb RR, de Prost D, and Mackman N: Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 1996;271:20828-20835.
51. Murthy U, Anzano MA, and Greig RG: Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines. Int J Cancer 1989;44:110-115.
52. Anzano MA, Rieman D, Prichett W, Bowen-Pope DF, and Greig R: Growth factor production by human colon carcinoma cell lines. Cancer Res 1989;49:2898-2904.
53. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, and Fauci AS: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-158.
54. Chaturvedi MM, Higuchi M, and Aggarwal BB: Effect of tumor necrosis factors, interferons, interleukins, and growth factors on the activation of NF-kappa B: Evidence for lack of correlation with cell proliferation. Lymphokine Cytokine Res 1994;13:309-313.
55. Daffada AA, Murray EJ, and Young SP: Control of activator protein-1 and nuclear factor kappa B activity by interleukin-1, interleukin-6 and metals in HEPG2 cells. Biochim Biophys Acta 1994;1222:234-240.
56. Kinter AL, Poli G, Fox L, Hardy E, and Fauci AS: HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 1995;154:2448-2459.
57. Stanley SK, Folks TM, and Fauci AS: Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet radiation. AIDS Res Hum Retroviruses 1989;5:375-384.
58. Zmudzka BZ and Beer JZ: Activation of human immunodeficiency virus by ultraviolet radiation. Photochem Photobiol 1990;52: 1153-1162.
59. Valerie K, Laster WS, Kirkham JC, and Kuemmerle NB: Ionizing radiation activates nuclear factor kappa B but fails to produce an increase in human immunodeficiency virus gene expression in stably transfected human cells. Biochemistry 1995;34:15768-15776.
60. Manome Y, Yao XJ, Kufe DW, Cohen EA, and Fine HA: Selective effects of DNA damaging agents on HIV long terminal repeat activation and virus replication in vitro. J Acquir Immune Defic Syndr Hum Retroviral 1996;11:109-116.
61. Valerie K, Laster WS, Cheng L, Kirkham JC, Reavey P, and Kuemmere NB: Signal transduction and HIV transcriptional activation after exposure to ultraviolet light and other DNA-damaging agents. Photochem Photobiol 1996;64:280-285.
62. Xu Y, Conway B, Montaner JS, O'Shaughnessy MV, and Greenstock CL: Effect of low-dose gamma radiation of HIV replication in human peripheral blood mononuclear cells. Photochem Photobiol 1996;64:238-241.